Literature DB >> 18822927

Hypercapnia and hypocapnia in neonates.

Wei Zhou1, Wen Liu.   

Abstract

BACKGROUND: The arterial partial pressure of carbon dioxide (PaCO2) represents the balance between CO2 production and consumption. Abnormal increase or decrease in PaCO2 can affect the body's internal environment and function. Permissive hypercapnia has aroused more attention as a novel ventilatory therapy. The aim of this study was to elucidate the effects of hypercapnia and hypocapnia on the functions of such neonatal organs as the lung and brain. DATA SOURCES: The PubMed database was searched with the keywords "hypocapnia", "hypercapnia" and "newborn".
RESULTS: Hypocapnia is a risk factor for potential damage to the central nervous system, such as periventricular leukomalacia, intraventricular hemorrhage, cerebral palsy, cognition developmental disorder, and auditory deficit. Hyperventilation can lessen pulmonary artery hypertension to certain extent, but hypocapnia can aggravate ischemia/reperfusion-induced acute lung injury. Severe hypercapnia can induce intracranial hemorrhage, even consciousness alterations, cataphora, and hyperspasmia. Permissive hypercapnia can improve lung injury caused by diseases of the respiratory system, lessen mechanical ventilation-associated lung injury, reduce the incidence of bronchopulmonary dysplasia and protect against ventilation-induced brain injury. In addition, permissive hypercapnia plays a role in expanding cerebral vessels and increasing cerebral blood flow.
CONCLUSIONS: Severe hypercapnia and hypocapnia can cause neonatal brain injury and lung injury. Permissive hypercapnia can increase the survival of neonates with brain injury or respiratory system disease, and lessen the brain injury and lung injury caused by mechanical ventilation. However, the mechanism of permissive hypercapnia needs further exploration to confirm its safety and therapeutic utility.

Entities:  

Mesh:

Year:  2008        PMID: 18822927     DOI: 10.1007/s12519-008-0035-5

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  38 in total

1.  Is neurointensive care really optional for comprehensive stroke care?

Authors:  J Claude Hemphill; Thomas Bleck; J Ricardo Carhuapoma; Cherylee Chang; Michael Diringer; Romergryko Geocadin; Stephan Mayer; Owen Samuels; Paul Vespa
Journal:  Stroke       Date:  2005-10-13       Impact factor: 7.914

2.  Both extremes of arterial carbon dioxide pressure and the magnitude of fluctuations in arterial carbon dioxide pressure are associated with severe intraventricular hemorrhage in preterm infants.

Authors:  Jorge Fabres; Waldemar A Carlo; Vivien Phillips; George Howard; Namasivayam Ambalavanan
Journal:  Pediatrics       Date:  2007-02       Impact factor: 7.124

3.  Severe hypocarbia in preterm infants and neurodevelopmental deficit.

Authors:  G Greisen; H Munck; H Lou
Journal:  Acta Paediatr Scand       Date:  1987-05

4.  Hypocapnia under hypotension induces apoptotic neuronal cell death in the hippocampus of newborn rabbits.

Authors:  J Ohyu; A Endo; M Itoh; S Takashima
Journal:  Pediatr Res       Date:  2000-07       Impact factor: 3.756

5.  Randomized trial of permissive hypercapnia in preterm infants.

Authors:  G Mariani; J Cifuentes; W A Carlo
Journal:  Pediatrics       Date:  1999-11       Impact factor: 7.124

6.  Permissive hypercapnia impairs pulmonary gas exchange in the acute respiratory distress syndrome.

Authors:  F Feihl; P Eckert; S Brimioulle; O Jacobs; M D Schaller; C Mélot; R Naeije
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

7.  Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants.

Authors:  M P Collins; J M Lorenz; J R Jetton; N Paneth
Journal:  Pediatr Res       Date:  2001-12       Impact factor: 3.756

8.  Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion.

Authors:  J G Laffey; M Tanaka; D Engelberts; X Luo; S Yuan; A K Tanswell; M Post; T Lindsay; B P Kavanagh
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

Review 9.  Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia.

Authors:  Namasivayam Ambalavanan; Waldemar A Carlo
Journal:  Semin Perinatol       Date:  2006-08       Impact factor: 3.300

Review 10.  Human pulmonary vascular responses to hypoxia and hypercapnia.

Authors:  K L Dorrington; N P Talbot
Journal:  Pflugers Arch       Date:  2004-10       Impact factor: 3.657

View more
  6 in total

1.  Choroid plexus aquaporin 1 and intracranial pressure are increased in obese rats: towards an idiopathic intracranial hypertension model?

Authors:  M Uldall; D K Bhatt; C Kruuse; M Juhler; I Jansen-Olesen; R H Jensen
Journal:  Int J Obes (Lond)       Date:  2017-03-27       Impact factor: 5.095

2.  A novel approach toward noninvasive monitoring of transcutaneous CO(2).

Authors:  Madhubanti Chatterjee; Xudong Ge; Yordan Kostov; Leah Tolosa; Govind Rao
Journal:  Med Eng Phys       Date:  2013-08-06       Impact factor: 2.242

3.  Agreement of Mixed Venous Carbon Dioxide Tension (PvCO2) and Transcutaneous Carbon Dioxide (PtCO2) Measurements in Ventilated Infants.

Authors:  Sinan Uslu; Ali Bulbul; Mesut Dursun; Umut Zubarioglu; Ebru Turkoglu; Omer Guran
Journal:  Iran J Pediatr       Date:  2015-01-19       Impact factor: 0.364

4.  Effects of Permissive Hypercapnia on Laparoscopic Surgery for Rectal Carcinoma.

Authors:  Lei Wang; Lina Yang; Jing Yang; Shiqiang Shan
Journal:  Gastroenterol Res Pract       Date:  2019-10-07       Impact factor: 2.260

5.  Accuracy of a battery-powered portable capnometer in premature infants.

Authors:  Eiji Hirakawa; Satoshi Ibara
Journal:  J Clin Monit Comput       Date:  2021-01-01       Impact factor: 1.977

Review 6.  Carbon dioxide levels in neonates: what are safe parameters?

Authors:  Sie Kei Wong; M Chim; J Allen; A Butler; J Tyrrell; T Hurley; M McGovern; M Omer; N Lagan; J Meehan; E P Cummins; E J Molloy
Journal:  Pediatr Res       Date:  2021-07-06       Impact factor: 3.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.